{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:01:24Z","timestamp":1770274884910,"version":"3.49.0"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100012399","name":"HHS | Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["HHSO100201000046C"],"award-info":[{"award-number":["HHSO100201000046C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>\n            Plazomicin is an aminoglycoside with activity against multidrug-resistant\n            <jats:italic>Enterobacteriaceae<\/jats:italic>\n            . Plazomicin is dosed on a milligram-per-kilogram-of-body-weight basis and administered by a 30-min intravenous infusion every 24\u2009h, with dose adjustments being made for renal impairment and a body weight (BW) of \u2265125% of ideal BW.\n          <\/jats:p>","DOI":"10.1128\/aac.02329-18","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T07:52:18Z","timestamp":1547797938000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies"],"prefix":"10.1128","volume":"63","author":[{"given":"Michael","family":"Trang","sequence":"first","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie D.","family":"Seroogy","sequence":"additional","affiliation":[{"name":"Achaogen, Inc., South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Van Wart","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata M.","family":"Bhavnani","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryun","family":"Kim","sequence":"additional","affiliation":[{"name":"Achaogen, Inc., South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline A.","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Achaogen, Inc., South San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Ambrose","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Rubino","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. 2014. Antimicrobial resistance: global report on surveillance 2014. http:\/\/www.who.int\/antimicrobial-resistance\/publications\/surveillancereport\/en\/. Accessed August 2018."},{"key":"e_1_3_3_3_2","unstructured":"Center for Disease Dynamics Economics and Policy (CDDEP). 2015. The state of the world's antibiotics 2015. https:\/\/cddep.org\/wp-content\/uploads\/2017\/06\/swa_edits_9.16.pdf. Accessed August 2018."},{"key":"e_1_3_3_4_2","unstructured":"U.S. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States 2013. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/. Accessed August 2018."},{"key":"e_1_3_3_5_2","unstructured":"European Centre for Disease Prevention and Control. 2017. Antimicrobial resistance surveillance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AMR-surveillance-Europe-2016.pdf. Accessed August 2018."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2157"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2017.83"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01709-16"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.33.30319"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv050"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2010.11.006"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/520991"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/649554"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/599376"},{"key":"e_1_3_3_16_2","unstructured":"European Association of Urology. 2018. Urological infections guidelines. http:\/\/uroweb.org\/guideline\/urological-infections\/. Accessed August 2018."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00572-10"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00236-18"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1179\/1973947812Y.0000000015"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00313-18"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.8b00001"},{"key":"e_1_3_3_22_2","volume-title":"Zemdri prescribing information","author":"Achaogen, Inc","year":"2018","unstructured":"Achaogen, Inc. 2018. Zemdri prescribing information. Achaogen, Inc, South San Francisco, CA."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.25"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00624-11"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.653"},{"key":"e_1_3_3_26_2","volume-title":"Abstr IDWeek","author":"Choi T","year":"2018","unstructured":"Choi T, Seroogy J, Sanghvi M, Dhuria SV. 2018. Mass balance, metabolism, and excretion of [14C]-plazomicin in healthy human subjects, poster 1400. Abstr IDWeek, San Francisco, CA."},{"key":"e_1_3_3_27_2","unstructured":"University of California San Francisco Infectious Diseases Management Program. 2013. Aminoglycoside dosing and monitoring recommendations. http:\/\/idmp.ucsf.edu\/aminoglycoside-dosing-and-monitoring-recommendations. Accessed August 2018."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.650"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1221021"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199902000-00010"},{"key":"e_1_3_3_31_2","volume-title":"Abstr ESCMID\/ASM Conf Drug Dev Meet Challenge Antimicrob Resist","author":"Trang M","year":"2018","unstructured":"Trang M, Rubino CM, Hammel JP, Seroogy JD, Kim A, Forrest A, Bhavnani SM. 2018. Assessment of AUC-based therapeutic drug management algorithms for plazomicin therapy in patients with bloodstream infection, poster 84. Abstr ESCMID\/ASM Conf Drug Dev Meet Challenge Antimicrob Resist, Lisbon, Portugal."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0636-7"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/2052-0492-2-31"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-288"},{"key":"e_1_3_3_35_2","volume-title":"Abstr Eur Congr Clin Microbiol Infect Dis","author":"Cass R","year":"2013","unstructured":"Cass R, Kostrub CF, Gotfried M, Rodvold K, Tack KJ, Bruss J. 2013. A double-blind, randomized, placebo-controlled study to assess the safety, tolerability, plasma pharmacokinetics and lung penetration of intravenous plazomicin in healthy subjects, poster 1637. Abstr Eur Congr Clin Microbiol Infect Dis, Berlin, Germany."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01989-17"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01128-18"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801467"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807634"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800719"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544100-00002"},{"key":"e_1_3_3_42_2","volume-title":"Abstr 52nd Intersci Conf Antimicrob Agents Chemother","author":"Louie A","year":"2012","unstructured":"Louie A, Fikes S, Liu W, VanScoy B, Cirz R, Drusano G. 2012. Pharmacodynamics of plazomicin in a neutropenic murine pneumonia model against Klebsiella pneumoniae (KPN), poster 41. Abstr 52nd Intersci Conf Antimicrob Agents Chemother, San Francisco, CA. American Society for Microbiology, Washington, DC."},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.04.010"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP66089"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_3_48_2","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois D","year":"1989","unstructured":"Du Bois D, Du Bois EF. 1989. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:303\u2013311.","journal-title":"Nutrition"},{"key":"e_1_3_3_49_2","first-page":"6663","article-title":"Guidance for industry on population pharmacokinetics; availability. Food and Drug Administration, HHS","volume":"64","author":"Food and Drug Administration","year":"1999","unstructured":"Food and Drug Administration. 1999. Guidance for industry on population pharmacokinetics; availability. Food and Drug Administration, HHS. Notice Fed Regist 64:6663\u20136664.","journal-title":"Notice Fed Regist"},{"key":"e_1_3_3_50_2","volume-title":"Selected papers of Hirotugu Akaike","author":"Akaike H","year":"1998","unstructured":"Akaike H. 1998. A new look at the statistical model identification. In Parzen E, Tanabe K, Kitagawa G (ed), Selected papers of Hirotugu Akaike. Springer, New York, NY."},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-011-9255-z"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470087978.ch15"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1997.tb04326.x"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002807400801104"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02329-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02329-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:42:17Z","timestamp":1645479737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02329-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1128\/AAC.02329-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.02329-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"2018-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02329-18"}}